Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | -.--% | -.--% |
2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
2023 | GENOWAY : Euroland initiates buy coverage | CF |
Business Summary
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Genetically Modified Mouse, Rat and Cell Line Models
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 14 | 100.0 % | 17 | 100.0 % | +21.64% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Founder | - | 99-02-28 | |
Benjamin Bruneau
DFI | Director of Finance/CFO | - | 15-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 99-02-28 | |
Raffy Kazandjian
BRD | Director/Board Member | - | - |
Patrick Blain
BRD | Director/Board Member | 72 | - |
Director/Board Member | - | - | |
Chief Executive Officer | - | - | |
Andre Tartar
BRD | Director/Board Member | - | - |
Director/Board Member | 59 | - | |
Laurent Fraisse
BRD | Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 9,046,590 | 5,763,972 ( 63.71 %) | 247,882 ( 2.740 %) | 63.71 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+22.10% | 46.55B | |
+46.45% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- ALGEN Stock
- GWYNF Stock
- Company genOway